James Brooks

1.9k total citations
35 papers, 754 citations indexed

About

James Brooks is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, James Brooks has authored 35 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 20 papers in Virology and 14 papers in Epidemiology. Recurrent topics in James Brooks's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (8 papers). James Brooks is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (8 papers). James Brooks collaborates with scholars based in Canada, United States and Switzerland. James Brooks's co-authors include Paul Sandstrom, Richard Pilon, Silvia Bertagnolio, Michael R. Jordan, Binhua Liang, Hezhao Ji, Zacharias E. Suntres, Pang N. Shek, Manon Ragonnet‐Cronin and William M. Switzer and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

James Brooks

35 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Brooks Canada 16 444 355 284 82 57 35 754
Craig Conover United States 16 424 1.0× 195 0.5× 309 1.1× 229 2.8× 19 0.3× 25 990
Mabula Kasubi Tanzania 15 247 0.6× 129 0.4× 382 1.3× 56 0.7× 73 1.3× 34 732
Francesca Zara Italy 15 335 0.8× 93 0.3× 283 1.0× 137 1.7× 11 0.2× 26 710
Jean-Marie Sire France 16 303 0.7× 244 0.7× 300 1.1× 110 1.3× 28 0.5× 34 749
Almoustapha Issiaka Maïga Mali 14 317 0.7× 227 0.6× 105 0.4× 43 0.5× 20 0.4× 39 507
G Rezza Italy 12 307 0.7× 83 0.2× 199 0.7× 60 0.7× 15 0.3× 22 596
Marina Selleri Italy 16 230 0.5× 117 0.3× 318 1.1× 77 0.9× 42 0.7× 38 539
Maphoshane Nchabeleng South Africa 14 319 0.7× 87 0.2× 289 1.0× 74 0.9× 34 0.6× 40 621
Katherine Link United States 6 194 0.4× 133 0.4× 478 1.7× 40 0.5× 9 0.2× 8 774
Sourav Sen India 14 304 0.7× 182 0.5× 101 0.4× 43 0.5× 9 0.2× 56 541

Countries citing papers authored by James Brooks

Since Specialization
Citations

This map shows the geographic impact of James Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Brooks more than expected).

Fields of papers citing papers by James Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Brooks. The network helps show where James Brooks may publish in the future.

Co-authorship network of co-authors of James Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of James Brooks. A scholar is included among the top collaborators of James Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Brooks. James Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shurgold, Jayson, Glenys Smith, Derek R. MacFadden, et al.. (2021). The impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clinical Microbiology and Infection. 28(3). 426–432. 39 indexed citations
2.
Enns, Eric, Binhua Liang, Rupert Capiña, et al.. (2019). A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance. Scientific Reports. 9(1). 8970–8970. 33 indexed citations
3.
Brooks, James, Christopher Bell, Nicolas L. Gilbert, et al.. (2018). Low levels of detectable pertussis antibody among a large cohort of pregnant women in Canada. Vaccine. 36(41). 6138–6143. 4 indexed citations
4.
Switzer, William M., Michael A. Schillaci, Ellsworth M. Campbell, et al.. (2017). Bayesian inference reveals ancient origin of simian foamy virus in orangutans. Infection Genetics and Evolution. 51. 54–66. 4 indexed citations
5.
Switzer, William M., Michael A. Schillaci, Manon Ragonnet‐Cronin, et al.. (2016). Detailed phylogenetic analysis of primate T-lymphotropic virus type 1 (PTLV-1) sequences from orangutans ( Pongo pygmaeus ) reveals new insights into the evolutionary history of PTLV-1 in Asia. Infection Genetics and Evolution. 43. 434–450. 11 indexed citations
6.
Ji, Hezhao, Robert Kozak, Mia J. Biondi, et al.. (2015). Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations. Virology. 477. 1–9. 32 indexed citations
7.
Ji, Hezhao, Li Yang, Binhua Liang, et al.. (2013). Pyrosequencing Dried Blood Spots Reveals Differences in HIV Drug Resistance between Treatment Naïve and Experienced Patients. PLoS ONE. 8(2). e56170–e56170. 12 indexed citations
8.
Kiptoo, Michael, James Brooks, Raphael Lihana, et al.. (2013). HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya. BMC Infectious Diseases. 13(1). 517–517. 13 indexed citations
9.
Brooks, James, et al.. (2013). Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions. BMC Infectious Diseases. 13(1). 509–509. 9 indexed citations
10.
Brooks, James & Paul Sandstrom. (2013). The Power and Pitfalls of HIV Phylogenetics in Public Health. Canadian Journal of Public Health. 104(4). e348–e350. 8 indexed citations
11.
Ragonnet‐Cronin, Manon, Bonita E. Lee, Sabrina S. Plitt, et al.. (2013). Baseline Clinical HIV Genotypes Are a Valid Measure of Transmitted Drug Resistance Within the Treatment-Naive Population. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(5). 443–447. 4 indexed citations
12.
Young, Peter W., Adolfo Vúbil, Ângelo Augusto, et al.. (2013). Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique. PLoS ONE. 8(7). e68213–e68213. 15 indexed citations
13.
Ragonnet‐Cronin, Manon, Stéphane Aris‐Brosou, Michael L. Rekart, et al.. (2012). Genetic Diversity as a Marker for Timing Infection in HIV-Infected Patients: Evaluation of a 6-Month Window and Comparison With BED. The Journal of Infectious Diseases. 206(5). 756–764. 34 indexed citations
14.
Steinberg, Malcolm, Darrel Cook, Mark Gilbert, et al.. (2011). Towards targeted screening for acute HIV infections in British Columbia. Journal of the International AIDS Society. 14(1). 39–39. 4 indexed citations
15.
Ji, Hezhao, Shaun Tyler, Binhua Liang, et al.. (2010). HIV Drug Resistance Surveillance Using Pooled Pyrosequencing. PLoS ONE. 5(2). e9263–e9263. 27 indexed citations
16.
Ragonnet‐Cronin, Manon, Marianna Ofner-Agostini, Richard Pilon, et al.. (2010). Longitudinal Phylogenetic Surveillance Identifies Distinct Patterns of Cluster Dynamics. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 102–108. 44 indexed citations
17.
Levy, Marlon F., Takele Argaw, Carolyn A. Wilson, et al.. (2007). No evidence of PERV infection in healthcare workers exposed to transgenic porcine liver extracorporeal support. Xenotransplantation. 14(4). 309–315. 15 indexed citations
18.
Brooks, James, et al.. (2006). Characterization of blood‐borne transmission of simian foamy virus. Transfusion. 47(1). 162–170. 35 indexed citations
19.
20.
Shek, Pang N., Zacharias E. Suntres, & James Brooks. (1994). Liposomes in Pulmonary Applications: Physicochemical Considerations, Pulmonary Distribution and Antioxidant Delivery. Journal of drug targeting. 2(5). 431–442. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Conover Breakdown of academic impact, for papers by Mabula Kasubi Breakdown of academic impact, for papers by Francesca Zara Breakdown of academic impact, for papers by Jean-Marie Sire Breakdown of academic impact, for papers by Almoustapha Issiaka Maïga Breakdown of academic impact, for papers by G Rezza Breakdown of academic impact, for papers by Marina Selleri Breakdown of academic impact, for papers by Maphoshane Nchabeleng Breakdown of academic impact, for papers by Katherine Link Breakdown of academic impact, for papers by Sourav Sen
Rankless by CCL
2026